Harrow (HROW) Amortization of Deferred Charges (2017 - 2026)
Harrow (HROW) recorded quarterly Amortization of Deferred Charges of $451000.0 in Q1 2026, up 25.98% quarter-over-quarter from $358000.0 in Q4 2025, and down 64.63% on a YoY basis from $1.3 million in Q1 2025.
Harrow (HROW) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Harrow's Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 64.63% year-over-year to $451000.0; the TTM figure through Mar 2026 stood at $2.5 million (down 14.44% YoY), while the FY2025 annual figure was $4.0 million, down 3.69% from the prior year.
- Amortization of Deferred Charges was $451000.0 for Q1 2026 at Harrow, up from $358000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $1.5 million in Q4 2023 to a low of $193000.0 in Q1 2022.
- Historically, Amortization of Deferred Charges has averaged $598058.8 across 5 years, with a median of $451000.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges soared 676.14% in 2023, then slumped 70.66% in 2025.
- A 5-year view of Amortization of Deferred Charges shows it stood at $197000.0 in 2022, then jumped by 676.14% to $1.5 million in 2023, then decreased by 20.21% to $1.2 million in 2024, then plunged by 70.66% to $358000.0 in 2025, then gained by 25.98% to $451000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $451000.0 (Q1 2026), $358000.0 (Q4 2025), and $745000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 451,000.00 |
| Mar 31, 2026 | 451,000.00 |
| Dec 31, 2025 | 358,000.00 |
| Dec 31, 2025 | 358,000.00 |
| Sep 30, 2025 | 745,000.00 |
| Sep 30, 2025 | 745,000.00 |
| Jun 30, 2025 | 916,000.00 |
| Jun 30, 2025 | 916,000.00 |
| Mar 31, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 197,000.00 |
| Sep 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Mar 31, 2024 | 976,000.00 |
| Mar 31, 2024 | 976,000.00 |
| Dec 31, 2023 | 1.53 Mn |
| Dec 31, 2023 | 1.53 Mn |